Menu
Log In Sign Up
Article

hcv peptide pool HCV Discovery Grade ImmuneSelect

Published October Oct 17, 2026 12:19 PM

In the realm of immunological research, the precision of tools HCV Sub Peptide Pool (>95% HPLC) | LB01717 used to study antigen-specific T cell responses is paramount. HCV Peptide (257-266) Among these, the HCV peptide pool has eme PEPTIDE POOLS - STEMCELL Technologies rged as a cornerstone for scientists investigating viral protein interactions and immune surveillance. As someone deeply engaged in the study of peptide-based assays, I have found that selecting the right configuration—whether it be a defined set of epitopes or an overlapping peptide scan—is critical for high-quality data generation.

Technical Specifications and Composition

When sourcing an HCV peptide pool, the configur Hepititis C virus (HCV) ImmuneSelect peptide poolis composed of 46 peptidesderived from the following proteins: Genome polyprotein (UniProt:P27958) F protein Read more ation varies significantly based on the intended application. For instance, a HCV ImmuneSelect Peptide Pool Premium is often utilized for its curated composition, frequently composed of 46 peptides derived from the genome polyprotein. These sets are meticulously designed to cover immunodominant sequences, providing a robust scaffold for experimental models.

Conversely, researchers focusing on comprehensive coverage often opt for larger sets, such as a pool of 200 peptides or a pool of 140 peptides. These are typically generated via peptide scans—often using 15-mers with 11 amino acid overlaps—to map the entire envelope or capsid protein of the virus. In other specialized laboratory settings, a HCV peptide pool consists of 21 peptides, each carefully selected to represent specific HLA class I-restricted T cell epitopes. This 21-peptide configuration is preferred when the objective is to isolate precise cellular responses without the noise of non-relevant sequences.

Applications in Immune Mapping

The primary function of these tools is to serve as a peptide pool for antigen-specific stimulation in T cell assays. Whether one is performing intracellular cytokine staining or ELISpot assays, the quality of the peptides determines the validity of the results.

A common methodology involves the use of HCV peptide pools at specific concentrations (often around 1µg/mL) to stimulate peripheral blood mononuclear cells (PBMCs). During my own observations of these workflows, I have noted that the matrix approach for Product Sheet epitope mapping—where each matrix pool (A to J Intracellular cytokine staining was performed by stimulation of cells from this same line with apoolofHCV peptidescorresponding to the tetramer epitopes.Read more and AA to JJ) consists of five HCV overlapping peptides—allows for the efficient identification of individual reactive sequences within a larger library.

This pool consists of21 peptides, each corresponding to a defined HLA class I-restricted T cell epitope from Hepatitis C virus (HCV).

Key Considerations for Experimental Design

When integrating these materials into your research, consider the following technical parameters:

* Purity and Quality: Always source HCV Discovery Grade ImmuneSelect or equivalent high-purity products (often >95% HPLC) to ensure consistent stimulation.

* Structural Integrity: Note that some protocols utilize HCV pp (peptide pool) that contain 18-mer peptides overlapping by 11 aa, which provides a different kinetic profile compared to standard 15-mers.

* Cross-reactivity: As noted in literature, HCV had a positive response to only one peptide pool in certain genotype studies, highlighting the importance of matching the pool genotype to the research objective.

* Versatility: You can use peptide pools for a broad range of applications, including vaccine research, immune cell surveillance, and diagnostic assay development.

Conclusion

The HCV peptide pool remains an indispensable asset for those dedicated to the study of hepatitis C virus immunology. By utilizing high-quality HCV peptides that are representing immunostimulatory epitopes in HIV, HCV, and other viruses, researchers can achieve a clearer picture of T cell behavior. Whether you are dealing with a small set of 21 peptides or a large library, the focus remains on the accuracy of the peptide delivery and the reproducibility of the cellular activation. These tools, which can be used for the research of hepatitis C virus (HCV), continue to drive innovation in our understanding of how complex viral proteins interact with the human immune system.

Leave a Comment
Get new articles in your inbox

News, updates and freebies. No spam, unsubscribe anytime.